Fortress Biotech Pref Preferred Stock Probability of Future Preferred Stock Price Finishing Over 5.18
| FBIOP Preferred Stock | USD 5.18 0.06 1.17% |
Fortress |
Fortress Biotech Target Price Odds to finish over 5.18
The tendency of Fortress Preferred Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.18 | 90 days | 5.18 | about 79.68 |
Based on a normal probability distribution, the odds of Fortress Biotech to move above the current price in 90 days from now is about 79.68 (This Fortress Biotech Pref probability density function shows the probability of Fortress Preferred Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Fortress Biotech has a beta of 0.68. This usually indicates as returns on the market go up, Fortress Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Fortress Biotech Pref will be expected to be much smaller as well. Additionally Fortress Biotech Pref has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Fortress Biotech Price Density |
| Price |
Predictive Modules for Fortress Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fortress Biotech Pref. Regardless of method or technology, however, to accurately forecast the preferred stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the preferred stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Fortress Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Fortress Biotech is not an exception. The market had few large corrections towards the Fortress Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fortress Biotech Pref, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fortress Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.4 | |
β | Beta against Dow Jones | 0.68 | |
σ | Overall volatility | 0.53 | |
Ir | Information ratio | -0.15 |
Fortress Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fortress Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fortress Biotech Pref can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fortress Biotech generated a negative expected return over the last 90 days | |
| Fortress Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 68.79 M. Net Loss for the year was (164.83 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech Pref has accumulated about 248.77 M in cash with (116.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. |
Fortress Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fortress Preferred Stock often depends not only on the future outlook of the current and potential Fortress Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fortress Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 66 M | |
| Cash And Short Term Investments | 305.7 M |
Fortress Biotech Technical Analysis
Fortress Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Fortress Preferred Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fortress Biotech Pref. In general, you should focus on analyzing Fortress Preferred Stock price patterns and their correlations with different microeconomic environments and drivers.
Fortress Biotech Predictive Forecast Models
Fortress Biotech's time-series forecasting models is one of many Fortress Biotech's preferred stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Fortress Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the preferred stock market movement and maximize returns from investment trading.
Things to note about Fortress Biotech Pref
Checking the ongoing alerts about Fortress Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Fortress Biotech Pref help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Fortress Biotech generated a negative expected return over the last 90 days | |
| Fortress Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 68.79 M. Net Loss for the year was (164.83 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech Pref has accumulated about 248.77 M in cash with (116.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.